Scotland, I went to work as a research fellow with Dr A M Dawson in Professor Sheila Sherlock's Medical Unit which was then housed in a hut perched on the rooftop of the Royal Free Hospital. Every Friday afternoon, international research workers in the unit used to disappear to attend a ward round conducted by Chris Booth at the Hammersmith Hospital. My colleagues assured me that these rounds were not to be missed and advised me to join them, adding the fact that when young ladies were present, Chris Booth performed even better. Alas, during the two years that I was at the Royal Free, I was unable to attend, but I can well believe them.
It was in 1964, after I had finished the general medical course at the Postgraduate Medical School, that I joined the Gastroenterology Unit as an unpaid clinical assistant for six months in order to prepare for the MRCP examination. During these months, and while Chris was away in Africa, I became involved in intubating patients with malabsorption caused by gastrectomy or by jejunal diverticulosis. It was Gilbert Thompson who asked whether I would be interested in investigating these patients. By the end of the six months, we had studied several patients and correlated their intestinal bacteriology with their B12 absorption and their faecal fat excretion and later related it to bile salt deconjugation. It was the beginning of a very stimulating and productive period which lasted until the end of 1970. I subsequently obtained a grant from the Review on 'Pathophysiological role of small intestinal bacterial flora' at the World Congress of Gastroenterology in Copenhagen in 1970.' These achievements were made possible by the support and encouragement we all had from Chris Booth. He was an enthusiastic and generous leader of the group, promoting individuality and encouraging potential. We are also indebted to the marvellous patients who were often as dedicated and as involved in clinical investigations as we were. A special name comes immediately to mind which other colleagues will readily recognise -Joe Hall -who did his own intubations and collected his own samples with the greatest precision. He kept a detailed diary of all events. Joe became a friend who still visits us socially. There were many others who joined in these studies and whom I frequently visited in their homes. It is evident that those were golden years at Hammersmith Hospital but for me all was to change when I married Chris Booth and we had our lovely daughter Nadya. I did not take easily to the role of Caesar's wife and it became obvious that I had not only to change hospitals, but also to change subjects. In In my laboratory we developed new methods based on -S-methionine labelled proteins, immunoblotting and DNA fingerprinting for differentiating between C difficile strains and applied them in epidemiological studies of C difficile-associated disease.
S Tabaqchali Use of 35S-methionine labelled proteins
The method is based on the incorporation of -"Smethionine into cellular proteins, their separation on SDS-PAGE followed by autoradiography. Briefly, 50 Lld prereduced methionine free medium (Difco) containing 1 1l (10 tCi) of '5S-methionine is inoculated with C difficile by touching two to three colonies of 48 hour pure culture on blood agar plates. The tubes are then incubated for two hours in an anaerobic chamber (10% H2, 10% C02, 80% N2). At the end of the incubation, the reaction is stopped by the addition of an equal volume of double strength cracking buffer, boiled at 100°C for two minutes, then cooled to room temperature and electrophoresed on SDS-polyacylamide gel. The method has been described in full elsewhere."" Using this method, nine distinct types were observed (designated A, B, C, D, E, W, X, Y, and Z), and six further types have more recently been identified, based on the demonstration of consistently present and easily identifiable dominant radiolabelled protein bands which are strain specific ( Fig. 1 ).
IMMUNOBLOTI ING (WESTERN BLOTTING)
To determine whether these radiolabelled protein bands were both specific and immunogenic, we investigated the common and specific antigenic determinants of the nine standard strains of C difficile by immunoblotting. ' Rabbit antisera were raised against each of these nine strains and immunoblotted against homologous and heterologous antigen preparations of the nine strains and against Clostridium sordellil and Clostridium septicum. By applying various pattern recognition software and normalisation procedures, it has been possible to apply numerical analysis and produce a dendrogram for eight of the 14 types. Further work is in progress to improve the software and produce a system which would identify the strain and the type within five to six hours.
Applications in epidemiological studies
Surveys of routine faecal specimens arriving in the laboratory were undertaken to establish the isolation rate of C difficile and its cytotoxin and to compare its incidence to that of other enteric pathogens. One thousand two hundred and thirty nine consecutive specimens from 856 patients were examined. C difficile was isolated from 69 patients giving an overall isolation rate of 8% with 32% in those under two years of age and 4% in those over two years of age. Cytotoxin producing strains were carried by 52% of positive patients and the percentage was higher in those over two years of age 64% compared to 46% in those under two years of age. Cytotoxin was detected in the stool of 10 patients; six infants and four adults.
The isolation rate of other enteric pathogens in the routine faecal specimens was less than that for C difficile; Salmonella strains tested (Fig. 3) . The relationship between toxin A and B production and the type of C difficile was also investigated in 170 strains isolated from 62 patients.21" There was a correlation between toxin production and type of strains. One hundred and forty seven of 172 strains were either high toxin producers (toxin A>40 ,ug/ml, toxin B >1:128) or low toxin producers and toxin was not detected from 28 strains. Types A and Y were consistently nontoxin producers whereas type E and W were highly toxigenic. Type X showed variable toxin production, but those X-strains isolated from the symptomatic oncology patients were high toxin producers. 
